Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.2
SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2021
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of changes in deferred revenue

Balance as of December 31, 2020

 

 

 

Short term

 

$ 63,331

 

Long term

 

 

72,281

 

Total as of December 31, 2020

 

$ 135,612

 

Cash payments received

 

 

8,496

 

Reclass to deferred grant

 

 

(28,350 )

Net sales recognized

 

 

(34,659 )

Balance as of September 30, 2021

 

 

81,099

 

Less short term

 

 

34,981

 

Long term

 

$ 46,118

 

Schedule of net sales

 

 

Three Months Ended

September 30,

 

 

 

2021

 

 

2020

 

Sales/access fees

 

$ -

 

 

$ 1,500

 

Distribution rights income

 

 

8,817

 

 

 

28,959

 

Membership/program fees

 

 

-

 

 

 

(650 )

Net sales

 

$ 8,817

 

 

$ 29,809

 

 

The following table presents the Company's net sales by product category for the nine months ended September 30, 2021 and 2020:

 

 

 

Nine months Ended

September 30,

 

 

 

2021

 

 

2020

 

Sales/access fees

 

$ -

 

 

$ 13,500

 

Distribution rights income

 

 

26,664

 

 

 

86,249

 

Membership/program fees

 

 

7,995

 

 

 

650

 

Net sales

 

$ 34,659

 

 

$ 100,399

 

Schedule of computations of weighted average shares outstanding

 

 

Nine months Ended

 

 

 

September 30,

 

 

 

2021

 

 

2020

 

Shares underlying options outstanding

 

 

818,631

 

 

$ 831,131

 

Shares underlying warrants outstanding

 

 

15,000

 

 

 

72,500

 

Convertible preferred stock outstanding

 

 

240,000

 

 

 

240,000

 

 

 

 

1,073,631

 

 

$ 1,143,631